Serum uric acid levels and neuromyelitis optica

Journal of Neurology

Volumn 257, Issue 6, 2010, Pages 1021-1026

  Peng, Fuhua ^a   Zhong, Xiufeng ^b   Deng, Xuhui ^a   Qiu, Wei ^a   Wu, Aimin ^a   Long, Youming ^a   Hu, Xueqiang ^a   Li, Qing ^a   Jiang, Ying ^a   Dai, Yongqiang ^a  

^a SUN YAT SEN UNIVERSITY   (China)

^b SUN YAT SEN UNIVERSITY   (China)

Author keywords

Multiple sclerosis; Neuromyelitis optica; Peroxynitrite; Uric acid

Indexed keywords

GADOLINIUM PENTETATE; URIC ACID;

ADOLESCENT; ADULT; ANALYZER; ARTICLE; BRAIN INFARCTION; CHILD; CHINESE; CONCENTRATION (PARAMETERS); CONTROL GROUP; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE DURATION; EXPANDED DISABILITY STATUS SCALE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MYELOOPTIC NEUROPATHY; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SCHOOL CHILD; URIC ACID BLOOD LEVEL; AGED; BLOOD; CASE CONTROL STUDY; CHINA; COHORT ANALYSIS; DISABILITY; MIDDLE AGED; MULTIPLE SCLEROSIS; PATHOLOGY; PRESCHOOL CHILD; SEVERITY OF ILLNESS INDEX; SEX DIFFERENCE; TIME; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; BRAIN INFARCTION; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; CHINA; COHORT STUDIES; DISABILITY EVALUATION; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; NEUROMYELITIS OPTICA; SEVERITY OF ILLNESS INDEX; SEX FACTORS; TIME FACTORS; URIC ACID; YOUNG ADULT;

EID: 77954426534     PISSN: 03405354     EISSN: 14321459     Source Type: Journal    
DOI: 10.1007/s00415-010-5455-1     Document Type: Article

References (27)

1. DC Hooper O Bagasra JC Marini A Zborek ST Ohnishi R Kean JM Champion AB Sarker L Bobroski JL Farber T Akaike H Maeda H Koprowski 1997 Prevention of experimental allergic encephalo-myelitis by targeting nitric oxide and peroxynitrite: implications for the treatment of multiple sclerosis Proc Natl Acad Sci USA 94 2528 2533 10.1073/pnas.94.6.2528 1:CAS:528:DyaK2sXhvF2ks7c%3D 9122229 (Pubitemid 27136909)
2. BN Ames R Cathcart E Schwiers P Hochstein 1981 Uric acid provides an antioxidant defense in humans against oxidant- and radical-caused aging and cancer: a hypothesis Proc Natl Acad Sci USA 78 6858 6862 10.1073/pnas.78.11.6858 1:CAS:528:DyaL38Xks1Gg 6947260 (Pubitemid 12216861)
3. DC Hooper GS Scott A Zborek T Mikheeva RB Kean H Koprowski SV Spitsin 2000 Uric acid, a peroxynitrite scavenger, inhibits CNS inflammation, blood-CNS barrier permeability changes, and tissue damage in a mouse model of multiple sclerosis FASEB J 14 691 698 1:CAS:528:DC%2BD3cXisFyhs7w%3D 10744626 (Pubitemid 30198568)
4. DC Hooper S Spitsin RB Kean JM Champion GM Dickson I Chaudhry H Koprowski 1998 Uric acid, a natural scavenger of peroxynitrite, in experimental allergic encephalo-myelitis and multiple sclerosis Proc Natl Acad Sci USA 95 675 680 10.1073/pnas.95.2.675 1:CAS:528:DyaK1cXmtFaisA%3D%3D 9435251 (Pubitemid 28083802)
5. GS Scott SV Spitsin RB Kean T Mikheeva H Koprowski DC Hooper 2002 Therapeutic intervention in experimental allergic encephalomyelitis by administration of uric acid precursors Proc Natl Acad Sci USA 99 16303 16308 10.1073/pnas.212645999 1:CAS:528:DC%2BD38Xps1ent74%3D 12451183 (Pubitemid 35462790)
6. DM Wingerchuk WF Hogancamp PC O'Brien BG Weinshenker 1999 The clinical course of neuromyelitis optica (Devic's syndrome) Neurology 53 1107 2214 1:STN:280:DyaK1MvisVGqtg%3D%3D 10496275
7. AA Argyriou N Makris 2008 Neuromyelitis optica: a distinct demyelinating disease of the central nervous system Acta Neurol Scand 118 4 209 217 10.1111/j.1600-0404.2008.01002.x 1:STN:280:DC%2BD1cnivVCmsQ%3D%3D 18336627
8. G Toncev B Milicic S Toncev G Samardzic 2002 Serum uric acid levels in multiple sclerosis patients correlate with activity of disease and blood-brain barrier dysfunction Eur J Neurol 9 221 226 10.1046/j.1468-1331.2002.00384.x 1:STN:280:DC%2BD38zgtFyjsA%3D%3D 11985629 (Pubitemid 35013907)
9. M Rentzos C Nikolaou M Anagnostouli A Rombos K Tsakanikas M Economou A Dimitrakopoulos M Karouli D Vassilopoulos 2006 Serum uric acid and multiple sclerosis Clin Neurol Neurosurg 108 527 531 10.1016/j.clineuro.2005.08.004 1:STN:280:DC%2BD28votVWksg%3D%3D 16202511 (Pubitemid 44209214)
10. CM Knapp CS Constantinescu JH Tan R McLean GR Cherryman I Gottlob 2004 Serum uric acid levels in optic neuritis Mult Scler 10 278 280 10.1191/1352458504ms1042oa 1:CAS:528:DC%2BD2cXlslGltrs%3D 15222691 (Pubitemid 38807454)
11. F Peng B Zhang X Zhong J Li G Xu X Hu W Qiu Z Pei 2008 Serum uric acid levels of patients with multiple sclerosis and other neurological diseases Mult Scler 14 2 188 196 10.1177/1352458507082143 1:CAS:528:DC%2BD1cXmt1eksLw%3D 17942520 (Pubitemid 351639627)
12. A Miller L Glass-Marmor M Abraham I Grossman S Shapiro Y Galboiz 2004 Bio-markers of disease activity and response to therapy in multiple sclerosis Clin Neurol Neurosurg 106 249 254 10.1016/j.clineuro.2004.02.008 15177778 (Pubitemid 38716156)
13. JF Kurtzke 1983 Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS) Neurology 33 1444 1452 1:STN:280:DyaL2c%2FktValsQ%3D%3D 6685237
14. DM Wingerchuk VA Lennon SJ Pittock CF Lucchinetti BG Weinshenker 2006 Revised diagnostic criteria for neuromyelitis optica Neurology 66 1485 1489 10.1212/01.wnl.0000216139.44259.74 1:STN:280:DC%2BD283ovVKitw%3D%3D 16717206 (Pubitemid 43958540)
15. CM Poser DW Paty L Scheinberg WI McDonald FA Davis GC Ebers KP Johnson WA Sibley DH Silberberg WW Tourtellotte 1983 New diagnostic criteria for multiple sclerosis: guidelines for research protocols Ann Neurol 13 227 231 10.1002/ana.410130302 1:STN:280:DyaL3s3gt1OgtQ%3D%3D 6847134 (Pubitemid 13158528)
16. CH Polman SC Reingold G Edan M Filippi HP Hartung L Kappos FD Lublin LM Metz HF McFarland PW O'Connor M Sandberg-Wollheim AJ Thompson BG Weinshenker JS Wolinsky 2005 Diagnostic criteria for multiple sclerosis: 2005 revisions to the "McDonald Criteria" Ann Neurol 58 840 846 10.1002/ana.20703 16283615 (Pubitemid 41746873)
17. CF Lucchinetti J Parisi W Bruck 2005 The pathology of multiple sclerosis Neurol Clin 23 1 77 105 10.1016/j.ncl.2004.09.002 15661089 (Pubitemid 40126916)
18. V Calabrese R Lodi C Tonon 2005 Oxidative stress, mitochondrial dysfunction and cellular stress response in Friedreich's ataxia J Neurol Sci 233 145 162 10.1016/j.jns.2005.03.012 1:CAS:528:DC%2BD2MXltVejur0%3D 15896810 (Pubitemid 40812334)
19. G Pentón-Rol M Cervantes-Llanos G Martínez-Sánchez JA Cabrera-Gómez CM Valenzuela-Silva O Ramírez-Nuñez M Casanova-Orta MA Robinson-Agramonte I Lopategui-Cabezas PA López-Saura 2009 TNF-alpha and IL-10 downregulation and marked oxidative stress in Neuromyelitis Optica J Inflamm (Lond) 6 18 10.1186/1476-9255-6-18
20. JR Kanwar 2005 Anti-inflammatory immunotherapy for multiple sclerosis/experimental autoimmune encephalomyelitis (EAE) disease Curr Med Chem 12 2947 2962 10.2174/092986705774462833 1:CAS:528:DC%2BD2MXht1Grt7jL 16378498 (Pubitemid 41672485)
21. GS Scott S Cuzzocrea T Genovese H Koprowski DC Hooper 2005 Uric acid protects against secondary damage after spinal cord injury Proc Natl Acad Sci USA 102 3483 3488 10.1073/pnas.0500307102 1:CAS:528:DC%2BD2MXitl2ksrw%3D 15728348 (Pubitemid 40328071)
22. S Kastenbauer U Koedel HW Pfister 1999 Role of peroxynitrite as a mediator of pathophysiological alterations in experimental pneumococcal meningitis J Infect Dis 180 1164 1170 10.1086/315048 1:CAS:528: DyaK1MXms1yqtr4%3D 10479144 (Pubitemid 30070200)
23. J Drulović I Dujmović N Stojsavljević S Mesaros S Andjelković D Miljković V Perić G Dragutinović J Marinković Z Lević M Mostarica Stojković 2001 Uric acid levels in sera from patients with multiple sclerosis J Neurol 248 2 121 126 10.1007/s004150170246 11284129 (Pubitemid 32245422)
24. H Koprowski SV Spitsin DC Hooper 2001 Prospects for the treatment of multiple sclerosis by raising serum levels of uric acid, a scavenger of peroxynitrite Ann Neurol 49 139 10.1002/1531-8249(200101)49:1<139::AID- ANA28>3.0.CO;2-A 1:CAS:528:DC%2BD3MXhsVylsrg%3D 11198290 (Pubitemid 32163024)
25. J Fang MH Alderman 2000 Serum uric acid and cardiovascular mortality: the NHANES I epidemiologic follow-up study, 1971-1992: National Health and Nutrition Examination Survey JAMA 283 2404 2410 10.1001/jama.283.18.2404 1:CAS:528:DC%2BD3cXjslSktLg%3D 10815083
26. S Sotgiu M Pugliatti A Sanna A Sotgiu ML Fois G Arru G Rosati 2002 Serum uric acid and multiple sclerosis Neurol Sci 23 183 188 10.1007/s100720200059 1:STN:280:DC%2BD3s%2FivVyntA%3D%3D 12536287 (Pubitemid 35345492)
27. DM Wingerchuk BG Weinshenker 2005 Neuromyelitis Optica Curr Treat Options Neurol 7 173 182 10.1007/s11940-005-0010-6 15814070 (Pubitemid 40894929)